loadpatents
name:-0.012747049331665
name:-0.013204097747803
name:-0.0022928714752197
Stevenson; Graeme Irvine Patent Filings

Stevenson; Graeme Irvine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stevenson; Graeme Irvine.The latest application filed is for "fused [1,2,4]thiadiazine derivatives which act as kat inhibitors of the myst family".

Company Profile
1.12.9
  • Stevenson; Graeme Irvine - Parkville AU
  • Stevenson; Graeme Irvine - Melbourne AU
  • Stevenson; Graeme Irvine - Victoria AU
  • Stevenson; Graeme Irvine - Harlow N/A GB
  • Stevenson; Graeme Irvine - Essex GB
  • Stevenson; Graeme Irvine - Saffron Walden GB
  • Stevenson; Graeme Irvine - Saffron Waldon GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family
App 20210380548 - Morrow; Benjamin Joseph ;   et al.
2021-12-09
Substituted Condensed Thiophenes As Modulators Of Sting
App 20210214333 - Morrow; Benjamin Joseph ;   et al.
2021-07-15
Tetrahydroisoquinoline derived PRMT5-inhibitors
Grant 10,494,376 - Bergman , et al. De
2019-12-03
Tetrahydroisoquinoline Derived Prmt5-inhibitors
App 20170298075 - Bergman; Ylva Elisabet ;   et al.
2017-10-19
Compounds which have activity at M.sub.1 receptor and their uses in medicine
Grant 8,426,443 - Cooper , et al. April 23, 2
2013-04-23
Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine
App 20120316196 - Cooper; David Gwyn ;   et al.
2012-12-13
Compounds which have activity at M.sub.1receptor and their uses in medicine
Grant 8,299,257 - Cooper , et al. October 30, 2
2012-10-30
Compounds which have activity at M.sub.1 receptor and their uses in medicine
Grant 8,278,328 - Cooper , et al. October 2, 2
2012-10-02
Compounds which have activity at M1 receptor and their uses in medicine
App 20100210687 - Cooper; David Gwyn ;   et al.
2010-08-19
Compounds which have activity at M1 receptor and their uses in medicine
App 20100204272 - Cooper; David Gwyn ;   et al.
2010-08-12
Sulphonamido-substituted bridged bicycloalkyl derivatives
Grant 7,365,196 - Belanger , et al. April 29, 2
2008-04-29
Gamma-secretase inhibitors
Grant 7,049,296 - Castro Pineiro , et al. May 23, 2
2006-05-23
Gamma-secretase inhibitors
Grant 6,984,626 - Nadin , et al. January 10, 2
2006-01-10
Sulphonamido-substituted bridged bicycloalkyl derivatives
App 20040029862 - Belanger, Patrice Charles ;   et al.
2004-02-12
Gamma-secretase inhibitors
App 20030100512 - Nadin, Alan John ;   et al.
2003-05-29
Gamma-secretase inhibitors
App 20030055005 - Castro Pineiro, Jose Luis ;   et al.
2003-03-20
Phenylindole derivatives as 5-HT2A receptor ligands
Grant 6,486,153 - Castro Pineiro , et al. November 26, 2
2002-11-26
Serine derivatives and their use as therapeutic agents
Grant 5,885,999 - Elliott , et al. March 23, 1
1999-03-23
Gem-disubstituted azacyclic tachykinin antagonists
Grant 5,760,018 - Baker , et al. June 2, 1
1998-06-02
4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists
Grant 5,661,162 - MacLeod , et al. August 26, 1
1997-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed